You are viewing the site in preview mode

Skip to main content

Table 5 Pharmaceutical Benefits Scheme (PBS) item numbers addressing health needs specific to Indigenous Peoples [126]

From: Medicare policy changes to primary health care funding for Australia’s indigenous Peoples 1996–2023: a scoping review

Drug

Indication

Albendazole*

Whipworm infestation

Aspirin*

Cardiovascular disease

Bisacodyl

Constipation

Chloramphenicol

Eye infection

Ciprofloxacin

Chronic suppurative otitis media

Ferrous Fumarate

Iron deficiency anaemia

Ferrous Fumarate + Folic Acid

Pregnancy

Folic Acid

Pregnancy

Glucose And Ketone Indicator Urine

Diabetes

Hydroxocobalamin

Anaemia

Ivermectin

Human sarcoptic scabies

Ketoconazole

Fungal or yeast infection

Miconazole

Fungal or yeast infection

Terbinafine

Fungal or yeast infection

Loperamide

Diarrhoea

Magnesium

Hypomagnesaemia

Molnupiravir

SARS-CoV-2 infection

Mupirocin

Staphylococcus aureus infection

Nicotine

Nicotine dependence

Paracetamol

Pain

Prednisolone Acetate + Phenylephrine

Severe eye inflammation

Terbinafine

Dermatophyte infection

Thiamine

Thiamine deficiency

Sodium Chloride + Potassium Chloride + Glucose Monohydrate + Citrate

Dehydration

  1. *Patient must be an Aboriginal or a Torres Strait Islander person